The Nurse Learning Module 4 will provide an overview of some of the common treatments for lymphoma/CLL. We will describe how the landscape is evolving with the introduction of new therapies over recent years.
The module will also explore the nursing implications of how new therapies for lymphoma & CLL has changed patient care.
Part 1: The evolving treatment landscape for lymphoma/CLL
Presented by Dr Katharine Lewis, Lymphoma Clinical/Research Fellow, Sir Charles Gairdner Hospital, Perth
Katharine is a Haematology Clinical/Research Fellow from the UK, who is working at Sir Charles Gairdner Hospital and Linear from August 2018. She graduated from the University of Nottingham in the UK in 2007 and has since completed most of her post graduate training in Nottingham, which is a large, tertiary referral centre for both malignant and non-malignant haematology, including stem cell transplantation.
Her particular field of interest is lymphoma, and she is working as a Lymphoma Clinical/Research Fellow.
Part 2: Patient care in the era of new therapies for lymphoma/CLL
Presented by Helena Furdas, Lymphoma Clinical Nurse Consultant, Sir Charles Gairdner Hospital, Perth.
Helena graduated from nursing at Curtin University in 2009 and shortly thereafter began her haematology experience in 2010 whilst working at Royal Perth Hospital on the Bone Marrow Transplant Unit. Since then she has continued to work in haematology and in 2015 transitioned with the State Centre for Allogeneic stem cell transplant to Fiona Stanley Hospital. Here she enjoyed working in the Cancer Centre providing care for patients to keep them well, happy and out of hospital. She was appointed by Sir Charles Gairdner Hospital as the Lymphoma Clinical Nurse Consultant in early 2020